These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 8880631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Placenta and myometrium--the two main sources of fibrinolytic components during pregnancy.
    Uszyński M, Maciejewski K, Uszyński W, Kuczyński J.
    Gynecol Obstet Invest; 2001; 52(3):189-93. PubMed ID: 11598362
    [Abstract] [Full Text] [Related]

  • 5. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M, de Groot CJ, Steegers EA, Geurts-Moespot A, Thomas CM, Steegers-Theunissen RP, Sweep FC.
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF.
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N.
    Pol J Pharmacol; 1996 Nov; 48(2):215-20. PubMed ID: 9112654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
    Koh SC, Anandakumar C, Biswas A, Fong YF.
    Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
    Mutoh S, Kobayashi M, Hirata J, Itoh N, Maki M, Komatsu Y, Yoshida A, Sasa H, Kuroda K, Kikuchi Y.
    Agents Actions Suppl; 1992 Jan; 38 ( Pt 2)():342-9. PubMed ID: 1462840
    [Abstract] [Full Text] [Related]

  • 15. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N, Maguire TM, Riisbro R, Geurts-Moespot A, O'Donovan N, Schmitt M, McGreal G, McDermott E, O'Higgins N, Brünner N, Sweep CG, Duffy MJ.
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy.
    Johansson A, Boman K, Cederquist K, Forsberg H, Olsson T.
    J Intern Med; 2001 Jun; 249(6):503-10. PubMed ID: 11422656
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Tissue-type plasminogen activator (T-PA) and plasminogen activator inhibitor (PAI-1) in human follicular fluid during gonadotropin-induced ovulation].
    Szymański W, Walentowicz M, Kotschy M.
    Ginekol Pol; 2003 Oct; 74(10):1386-91. PubMed ID: 14669449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.